Skip to content

Ghrelin concentrations in gestational diabetes.

Ghrelin concentrations in gestational diabetes. - The GD-Ghrelin Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43473
Enrollment
38
Registered
2017-01-10
Start date
2016-07-05
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes in pregnancy gestational diabetes

Interventions

None listed

Sponsors

Maasstadziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - * 18 yr old - Able to read and communicate in Dutch - Singleton pregnancy - Gestational age: 24-28 weeks

Exclusion criteria

Exclusion criteria: - Pre-existent type 2 diabetes or glucose intolerance - History of gastrointestinal surgery - Hormonal treatment before or during pregnancy, including insulin

Design outcomes

Primary

MeasureTime frame
Primary Objective: To compare ghrelin concentrations in pregnancy in women with GD and without GD.

Secondary

MeasureTime frame
Secondary objective: 1. The determine the AG/UAG ratio in women with GD and without GD. 2. To determine the (fasting) adiponectin, leptin, glucose, insulin and HbA1c levels in women with GD and without GD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)